Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 23, 2022, Pharma-Bio Serv, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). Below is a summary of the proposals and corresponding votes.

Howard Spindel was elected as a Class III director to serve for a term until the 2025 Annual Meeting of Stockholders or until his successor is duly elected and qualified. Howard Spindel received the following votes:





   Nominee     Votes For  Votes Withheld
Howard Spindel 13,636,564     2,101

There were 2,639,780 broker non-votes on this proposal.

The ratification of the selection of Crowe PR PSC as the Company's independent certified public accountants for the fiscal year ending October 31, 2022 received the following votes:





Votes For  Votes Against Abstain
16,276,343     1,302       800

There were no broker non-votes on this proposal.

The non-binding advisory vote on the compensation of the named executive officers of the Company received the following votes:





Votes For  Votes Against Abstain
13,625,761     5,630      7,274

There were 2,639,780 broker non-votes on this proposal.






2

© Edgar Online, source Glimpses